A detailed history of Gamma Investing LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Gamma Investing LLC holds 81 shares of URGN stock, worth $935. This represents 0.0% of its overall portfolio holdings.

Number of Shares
81
Previous 36 125.0%
Holding current value
$935
Previous $604,000 70.36%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$12.7 - $17.92 $571 - $806
45 Added 125.0%
81 $1.03 Million
Q2 2024

Jul 02, 2024

BUY
$12.72 - $19.2 $203 - $307
16 Added 80.0%
36 $604,000
Q1 2024

Apr 05, 2024

BUY
$13.81 - $19.33 $276 - $386
20 New
20 $300,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $263M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.